Supernus Pharmaceuticals (SUPN) Earnings Date, Estimates & Call Transcripts $35.57 -0.61 (-1.69%) (As of 11/15/2024 08:55 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Supernus Pharmaceuticals Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 25EstimatedActual EPS (Nov. 4) $0.69 Beat By $0.25 Consensus EPS (Nov. 4) $0.44 Supernus Pharmaceuticals released Q3 2024 earnings on November 4, 2024, reporting an EPS of $0.69, which topped analysts' consensus estimates of $0.44 by $0.25. Quarterly revenue rose 14.2% year-over-year to $175.70 million, above analyst estimates of $157.35 million. With a trailing EPS of $1.07 and a P/E Ratio of 33.24, Supernus Pharmaceuticals' earnings are expected to decrease -40.93% next year, from $2.37 to $1.40 per share. Conference Call TranscriptConference Call AudioSEC 10-Q/10-K FilingSUPN Upcoming EarningsSupernus Pharmaceuticals' next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules. Skip Charts & View Estimated and Actual Earnings DataSUPN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SUPN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Chaikin AnalyticsTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. Supernus Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$2.37 EPSNext Year EPS Consensus Estimate: $1.40 EPS Supernus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/25/2025(Estimated)------- 11/4/2024Q3 2024$0.44$0.69+$0.25$1.21$157.35M$175.70M 8/6/2024Q2 2024$0.39$0.36 -$0.03$0.36$148.83M$168.30M 2/27/2024Q4 2023$0.41$0.02 -$0.39$0.02$155.03M$164.30M 11/8/2023Q3 2023$0.13-$0.29 -$0.42-$0.29$143.39M$153.88M 8/8/2023Q2 2023$0.23-$0.02 -$0.25-$0.02$143.63M$135.56M 5/9/2023Q1 2023$0.12$0.29+$0.17$0.29$139.02M$153.80M THIS is even better than AI (Ad)The all-new Apollo Smart Algo is revolutionizing trading as we know it... Not only has this first-of-its-kind “smart algo” been averaging 2.8 wins per day since inception… On stocks that are on the verge of breaking out… But it tells you exactly when to buy in before the big move could happen! Click Here to Experience the Future of Trading. 2/28/2023Q4 2022$0.73$0.43 -$0.30$0.43$180.38M$167.33M Supernus Pharmaceuticals Earnings - Frequently Asked Questions When is Supernus Pharmaceuticals's earnings date? Supernus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on SUPN's earnings history. What guidance has Supernus Pharmaceuticals issued on next quarter's earnings? Supernus Pharmaceuticals issued an update on its FY 2024 earnings guidance on Monday, November, 4th. The company issued revenue guidance of $630.0 million-$650.0 million, compared to the consensus revenue estimate of $619.5 million. Did Supernus Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Supernus Pharmaceuticals (NASDAQ:SUPN) reported $0.69 earnings per share (EPS) to beat the analysts' consensus estimate of $0.44 by $0.25. Learn more on analysts' earnings estimate vs. SUPN's actual earnings. How can I listen to Supernus Pharmaceuticals's earnings conference call? The conference call for Supernus Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Supernus Pharmaceuticals's conference call transcript? The conference call transcript for Supernus Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Supernus Pharmaceuticals's earnings report? Supernus Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Supernus Pharmaceuticals generate each year? Supernus Pharmaceuticals (NASDAQ:SUPN) has a recorded annual revenue of $651.97 million. How much profit does Supernus Pharmaceuticals generate each year? Supernus Pharmaceuticals (NASDAQ:SUPN) has a recorded net income of $1.32 million. SUPN has generated $1.07 earnings per share over the last four quarters. What is Supernus Pharmaceuticals's price-to-earnings ratio? Supernus Pharmaceuticals (NASDAQ:SUPN) has a trailing price-to-earnings ratio of 33.24 and a forward price-to-earnings ratio of 15.01. What is Supernus Pharmaceuticals's EPS forecast for next year? Supernus Pharmaceuticals's earnings are expected to decrease from $2.37 per share to $1.40 per share in the next year, which is a -40.93% change. ` More Earnings Resources from MarketBeat Related Companies OCUL Earnings Results KNSA Earnings Results ARQT Earnings Results INVA Earnings Results PHAT Earnings Results ORIC Earnings Results KPTI Earnings Results BTAI Earnings Results JAZZ Earnings Results CORT Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for Investors Tech funds are hemorrhaging cash: Sell this stock now (Ad)Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. This page (NASDAQ:SUPN) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Supernus Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SUPN Stock Alerts